Skip to main content
NGNE logo

NGNE

Neurogene Inc.
$35.34 +1.46 (+4.31%) At close · Jul 2
Market Cap
$558.44M
Shares
15,801,901

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 97
Total Value: $344,901,969
Total Shares: 17,108,236

Institutional Ownership Trend

10 quarters

Holder Concentration

Across 97 13F filers · Δ vs Dec 31, 2025
Top Holder
10.0%
Dec 2023 → Mar 2026 · range 9.9% – 13.8%
−0.4 pts
Top 5
42.3%
Dec 2023 → Mar 2026 · range 42.3% – 57.6%
−0.8 pts
Top 10
66.7%
Dec 2023 → Mar 2026 · range 66.7% – 87.0%
−0.9 pts
HHI
547
Dec 2023 → Mar 2026 · range 547 – 886
Broadly held−16

Quarterly Activity

vs Dec 31, 2025
New
18
Increased
45
Decreased
16
Sold Out
15
Unchanged
18
Holder count: +3
Institutional value: +1.4%
Shares held: +3.6%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 100 of 100
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1404644 CUSIP 64135M105 Visit website Investor relations